info@ehidc.org

 202-624-3270

Policy

Topic intro description here. Limited to 145 characters. Topic intro description here. Limited to 145 characters. Topic intro description here.

Consumer Health Privacy Framework Steering Committee Meeting (Steering Committee Only)

With funding from the Robert Wood Johnson Foundation (RWJF), the Foundation for eHealth Initiative (eHI) and the Center for Democracy & Technology (CDT) are collaborating on Building a Consumer Privacy Framework for Health Data, designed to address the current gaps in legal protections for health data outside HIPAA’s coverage.

Workgroup: Consumer Health Privacy Framework Substance (Workgroup Members Only)

With funding from the Robert Wood Johnson Foundation (RWJF), the Foundation for eHealth Initiative (eHI) and the Center for Democracy & Technology (CDT) are collaborating on Building a Consumer Privacy Framework for Health Data, designed to address the current gaps in legal protections for health data outside HIPAA’s coverage.

Workgroup: Consumer Health Privacy Framework Structure (Workgroup Members Only)

With funding from the Robert Wood Johnson Foundation (RWJF), the Foundation for eHealth Initiative (eHI) and the Center for Democracy & Technology (CDT) are collaborating on Building a Consumer Privacy Framework for Health Data, designed to address the current gaps in legal protections for health data outside HIPAA’s coverage.

COVID-19 Federal Policy Work Group: Artificial Intelligence & Machine Learning (Members Only)

Our COVID-19 Federal Policy Work Group series to help craft a report with a set of recommendations to fully leverage health IT and digital health to fight COVID-19 and future public health challenges. This meeting will focused on artificial intelligence and machine learning. 

Our guest speaker was Eileen Koski, Program Director, Health Data and Insights, Center for Computational Health, IBM Research who will discuss how IBM has deployed AI in the fight against COVID-19. 

Defining the clinician’s role in early health technology assessment during medical device innovation

April 23, 2020

Background: Early Health Technology Assessment (EHTA) is an evolving field in health policy which aims to provide decision support and mitigate risk during early medical device innovation. The clinician is a key stakeholder in this process and their role has traditionally been confined to assessing device efficacy and safety alone. There is however, no data exploring their role in this process and how they can contribute towards it. This motivated us to carry out a systematic review to delineate the role of the clinician in EHTA as per the PRISMA guidelines.

 

Methods: A systematic search of peer reviewed literature was undertaken across PUBMED, OVID Medline and Web of science up till June 2018. Studies that were suitable for inclusion focused on clinician input in health technology assessment or early medical device innovation. A qualitative approach was utilised to generate themes on how clinicians could contribute in general and specific areas of EHTA. Data was manually extracted by the authors and themes were agreed in consensus using a grounded theory framework. The specific stages included: All stages of EHTA, Basic research on mechanisms, Targeting for specific product, Proof of principle and Prototype and product development. Bias was assessed utilising the NICE Qualitative checklist.